STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas

Citation
N. Sato et al., STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas, AM J PATH, 159(6), 2001, pp. 2017-2022
Citations number
46
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
159
Issue
6
Year of publication
2001
Pages
2017 - 2022
Database
ISI
SICI code
0002-9440(200112)159:6<2017:SPGIII>2.0.ZU;2-J
Abstract
Despite the growing awareness of intraductal papillary-mucinous neoplasms ( IPMNs) of the pancreas among clinicians, the molecular features of IPMNs ha ve not been well characterized. Previous reports suggest that inactivation of the STK11/LKB1, a tumor-suppressor gene responsible for Peutz-Jeghers sy ndrome (PJS), plays a role in the pathogenesis of gastrointestinal hamartom as as weft as several cancers, including pancreatic adenocarcinoma. Using p olymerase chain reaction amplification of five microsatellite markers from the 19p13.3 region harboring the STK11/LKB1 gene, we analyzed DNA from 22 I PMNs for loss of heterozygosity (LOH). LOH at 19p13.3 was identified in 2 o f 2 (100%) IPMNs from patients with PJS and 5 of 20 (25%) from patients lac king features of PJS (7 of 22, 32% overall). Sequencing analysis of the STK 11/LKB1 gene in these IPMNs with LOH revealed a germline mutation in one IP MN that arose in a patient with PJS and a somatic mutation in 1 of the 20 s poradic IPMNs. None of the 22 IPMNs showed hypermethylation of the STK11/LK B1 gene. These results suggest that the STK11/LKB1 gene is involved in the pathogenesis of som IPMNs.